Postinflammatory hyperpigmentation: A comprehensive overview Treatment options and prevention
Postinflammatory hyperpigmentation: A comprehensive overview Treatment options and prevention
复制标题
DOI：
10.1016/j.jaad.2017.01.036
复制
发表时间：
2017-10-01
影响因子：
13.8
通讯作者：
Hamzavi, Iltefat
中科院分区：
文献类型：
--
作者：
Chaowattanapanit, Suteeraporn;Silpa-archa, Narumol;Hamzavi, Iltefat
炎症后色素沉着过度（PIH）发生在各种皮肤病、外源性刺激和皮肤科手术后。妊高征的临床过程是慢性的和不可预测的，虽然解决的可能性表皮色素沉着比真皮色素沉着。PIH可以预防或缓解。当它确实发生时，应该寻找和治疗潜在的炎症条件，作为减少炎症和PIH（这是一种炎症后果）进展的第一步。如果炎症条件消退或在诊断时没有炎症的证据，则应考虑PIH的治疗作为下一步。了解可用的治疗方案有助于医生为每位患者选择合适的治疗方案。有一个可重复的模型妊高征是必不可少的发展的治疗方式。在这两部分继续医学教育系列的第二篇文章中，专门讨论了支持妊高征和其他形式的获得性色素沉着过度的医学和程序治疗的证据。它还描述了一个妊高征模型，并提供了一个算法的临床实践沿着讨论有关预防妊高征。
Postinflammatory hyperpigmentation (PIH) occurs after various dermatoses, exogenous stimuli, and dermatologic procedures. The clinical course of PIH is chronic and unpredictable, although the probability of resolution of epidermal hyperpigmentation is better than those of dermal hyperpigmentation. PIH can be prevented or alleviated. When it does occur, the underlying inflammatory conditions should be sought and treated as the first step to reduce the progression of inflammation and PIH (which is an inflammatory consequence). If the inflammatory conditions subsides or there is no evidence of inflammation at the time of diagnosis, the treatments of PIH should be considered as the next step. Understanding the available treatment options helps the physician choose the appropriate treatment for each patient. Having a reproducible model for PIH is essential for the development of treatment modalities. The second article in this 2-part continuing medical education series on PIH specifically addresses the evidence that supports medical and procedural treatments of PIH and other forms of acquired hyperpigmentation. It also describes a PIH model and provides an algorithm for clinical practice along with discussion about the prevention of PIH.